ESC 365 - Re-classification of hypertrophic cardiomyopathy genetic variants in patients from the sarcomeric human cardiomyopathy registry (SHaRe)

ESC2025 Premium Access

Re-classification of hypertrophic cardiomyopathy genetic variants in patients from the sarcomeric human cardiomyopathy registry (SHaRe)

Session: Hypertrophic cardiomyopathy: from gene to treatment

Topic: Hypertrophic Cardiomyopathy

Speaker: Ms S. Hespe (Sydney, AU)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Ms Sophie Hespe

Sydney (Australia)

0 follower

7 more presentations in this session

Physical activity measured by accelerometry in hypertrophic cardiomyopathy: findings from the AFFECT-HCM study

Speaker: Doctor S. Schoonvelde (Rotterdam, NL)

Minimally invasive electro septal myectomy for hypertrophic obstructive cardiomyopathy via right infra-axillary incision

Speaker: Professor Y. Cui (Hangzhou, CN)

Mavacamten treatment in obstructive hypertrophic cardiomyopathy for up to 30 weeks: An integrated analysis of cardiac magnetic resonance data from a diverse population in randomized clinical trials

Speaker: Doctor C. Kramer (Charlottesville, US)

Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM

Speaker: Doctor S. Saberi (Ann Arbor, US)

Worse prognosis for sudden cardiac death events and progression to the burned-out phase in non-obstructive hypertrophic cardiomyopathy: insights from the REVEAL-HCM Registry

Speaker: Doctor A. Kimura (Okayama, JP)

Access the full session

Hypertrophic cardiomyopathy: from gene to treatment

Speakers: Ms S. Hespe, Doctor S. Schoonvelde, Professor Y. Cui, Doctor C. Kramer, Doctor S. Saberi...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources